MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Conferences and Meetings
2026: OPMED 2026_Operational Medicine (OpMed) SYMPOSIUM & TECHNOLOGY SHOWCASE March 17-18 2026, San Antonio, Texas
Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. (HJF)
Organization & Developments: HJF (Henry M. Jackson Foundation)
HJF: Locations
Japan
Industry: Japan
3-D Matrix Medical Technology, Inc. - Puramatrix
Organization & Developments: 3-D Matrix Medical Technology
Parents
3-D Matrix Medical Technology, Inc. - Puramatrix
Children
2014: 3-D Matrix sues for patent infringement over cell scaffold product
and PuraMatrixGMP clinical-grade gels for orthopedics, bioproduction, and drug delivery.
Biomaterials company, engages in developing medical therapies for accelerating wound healing and tissue regeneration across a range of medical indications for pharmaceutical companies, biotech labs, and academic laboratories.
Its products also include PuraMatrix synthetic peptide hydrogels that serve as a synthetic three-dimensional extracellular matrix cell culture gel
PuraMatrix gels consist of smart polymers, self-assembling in cell culture or in vivo to create biocompatible nanofiber scaffolds to facilitate healthy cell growth and tissue regeneration
PuraMatrix with self-assembling domain and functional motif functionalities to improve cell adhesion and cell migration
PuraMatrix, a peptide hydrogel synthetic matrix material to create three-dimensional micro-environments for various cell culture and in vivo experiments, as well as for tissue regeneration, cell therapies, and drug delivery system applications
PuraMatrixHC high concentration gels with tissue retention and therapeutic delivery properties for cell culture and tissue engineering applications
Jumps
*Key People: Matrix
Finance & Acquisitions: 3-D Matrix Medical Technology